Medical Equipment

Global Cardiac Marker Market Report 2026–2035: Key Forecasts and Growth Areas

February 2, 2026February 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the software as a service (saas) testing tool market from 2026–2035 with trusted insights from The Business Research Company

How much is the Cardiac Marker Market valued at in 2026, and what valuation is forecast for 2030?_x000D_

The cardiac marker market has experienced rapid expansion in its valuation recently. It is projected to escalate from $12.38 billion in 2025 to $13.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. This historical growth can be ascribed to factors such as the increasing incidence of cardiovascular diseases, the enlargement of hospital laboratory infrastructure, a surge in the utilization of emergency cardiac testing, a heightened dependence on biomarker-based diagnosis, and enhancements in assay sensitivity._x000D_

_x000D_

The cardiac marker market is projected for significant expansion in the coming years, reaching a valuation of $22.7 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.9%. This anticipated growth throughout the forecast period stems from factors such as a heightened demand for quicker diagnostic test results, the escalating integration of cardiac diagnostic methods with digital platforms, the broader availability of point-of-care testing facilities, the increasing use of sophisticated biomarker panels, and a greater emphasis on precision cardiology. Key trends anticipated during this period encompass the expanded application of high-specificity cardiac marker panels, a surge in the adoption of automated immunoassay systems, an escalating need for swift cardiac diagnoses, the proliferation of multiparametric testing methodologies, and a stronger emphasis on supporting clinical decision-making._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp_x000D_

_x000D_

What Drivers Are Influencing The Growth Of The Cardiac Marker Market?_x000D_

The escalating occurrence of cardiac conditions is projected to boost the expansion of the cardiac marker market in the foreseeable future. These diseases encompass various ailments impacting the heart’s structure or function, leading to diverse health complications. Cardiac markers serve as diagnostic and monitoring tools for numerous heart-related issues, such as heart attacks, angina, heart failure, and other forms of cardiovascular illness. Consequently, the need for diagnostic tests utilizing cardiac markers has risen. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, showing a 4.0% increase from 224.4 per 100,000 in 2023. This indicates that the increasing occurrence of cardiac ailments will significantly contribute to the cardiac marker market’s expansion._x000D_

_x000D_

What Segments Are Included Within The Cardiac Marker Market?_x000D_

The cardiac marker market covered in this report is segmented – _x000D_

_x000D_

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers_x000D_

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA_x000D_

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications_x000D_

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions_x000D_

_x000D_

Subsegments:_x000D_

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits_x000D_

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels_x000D_

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels_x000D_

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels_x000D_

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)_x000D_

_x000D_

Which Innovation Trends Are Advancing Developments Within The Cardiac Marker Market?_x000D_

Major companies operating in the cardiac marker market are emphasizing innovative products like high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers to increase their market revenues. High-sensitivity troponin I (hs-cTnI) and NT-proBNP are two crucial cardiac biomarkers utilized for diagnosis, classification, and treatment. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based company specializing in medical equipment and solutions development, manufacturing, and distribution, launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimal requirements for hs-cTn concerning sensitivity, accuracy, and reliability in detecting myocardial damage. These new products are designed to support enhanced treatment for cardiovascular illnesses by offering dependable solutions that improve patient outcomes both within and beyond cardiovascular disease contexts._x000D_

_x000D_

Who Are The Primary Competitors In The Global Cardiac Marker Market?_x000D_

Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics _x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report_x000D_

_x000D_

Which Global Regions Are Shaping The Competitive Landscape Of The Cardiac Marker Market?_x000D_

North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized Cardiac Marker Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company#_x000D_

_x000D_

Arrhythmia Monitoring Devices Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report_x000D_

_x000D_

Cardiac Arrhythmia Monitoring Devices Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report_x000D_

_x000D_